# US 2010/0143414 A1 · Pneumococcal serotypes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0143414 A1
- Document ID: US20100143414A1
- Status: Published application
- Kind: A1
- Application number: 12/097,815
- Filed: 2006-12-28
- Published: 2010-06-10
- Earliest claimed: 2005-12-28
- Assignees: University of Alabama Research Foundation
- Inventors: Moon H. Nahm; Jisheng Lin; Angela P. Brandao; Maria Cristina Brandileone
- Web page: https://patentgrep.com/patent/US20100143414A1

## CPC

- C12Q 1/689: for bacteria
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 31/04: Antibacterial agents
- C08B 37/0003: {General processes for their isolation or fractionation, e.g. purification or extraction from biomass}
- A61K 39/00: Medicinal preparations containing antigens or antibodies (materials for immunoassay G01N33/53)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C08B: POLYSACCHARIDES; DERIVATIVES THEREOF (polysaccharides containing less than six saccharide radicals attached to each other by glycosidic linkages C07H; fermentation or enzyme-using processes C12P19/00; sugar industry C13; production of cellulose D21)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Disclosed is a new and emerging serotype of Streptococcus pneumoniae designated serotype 6C, and assays and monoclonal antibodies useful in identifying same. Also disclosed is a novel pneumococcal polysaccharide with the repeating unit {→2) glucose 1 (1→3) glucose 2 (1→3) rhamnose (1→3) ribitol (5→phosphate}. This new serotype may be included in pneumococcal vaccines.

## Claims

### Claim 1

An isolated culture of a bacterium designated Streptococcus pneumoniae 6C.

### Claim 2

A vaccine comprising a polysaccharide or portion of a polysaccharide derived from the bacterium designated Streptococcus pneumoniae 6C.

### Claim 3

A purified polysaccharide comprising the repeating unit {→2) glucose 1 (1→3) glucose 2 (1→3) rhamnose (1→3) ribitol (5→phosphate}.

### Claim 4

A vaccine comprising a polysaccharide having the repeating unit {→2) glucose 1 (1→3) glucose 2 (1→3) rhamnose (1→3) ribitol (5→phosphate}.

### Claim 5

An antigen binding molecule that binds to Streptococcus pneumoniae 6C.

### Claim 6

An antigen binding molecule that differently binds to Streptococcus pneumoniae 6A(6Aα) and Streptococcus pneumoniae 6C.

### Claim 7

A chemical or genetic test that differentiates for Streptococcus pneumoniae 6C.
